Strata Critical Medical (SRTA) FCF Margin (2020 - 2026)

Strata Critical Medical has disclosed FCF Margin across 7 years of filings, most recently posting 1.92% for Q1 2026.

• In Q1 2026, FCF Margin fell 29.0% year-over-year to 1.92%; the TTM figure through Mar 2026 stood at 19.57% (down 3543.0% YoY), while the FY2025 annual figure was 24.88%, down 2291.0% from the prior year.
• FCF Margin declined to 1.92% in Q1 2026, from 1.03% in the prior quarter.
• Over the last five years, FCF Margin for SRTA reached as high as 66.39% in Q4 2024 and fell as low as 81.39% in Q3 2025.
• The 5-year median for FCF Margin is 10.8% (2025), against an average of 15.02%.
• Annual changes were most pronounced in 2024 — FCF Margin jumped 8163 bps — and 2025, when it tumbled 7802 bps.
• A 5-year view of FCF Margin shows it stood at 62.59% in 2022, then soared by 76 bps to 15.24% in 2023, then surged by 536 bps to 66.39% in 2024, then plunged by 102 bps to 1.03% in 2025, then slumped by 86 bps to 1.92% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 1.92%, 1.03%, and 81.39% for Q1 2026, Q4 2025, and Q3 2025 respectively.